FCMI
Foresite Capital Management III Portfolio holdings
AUM
$37.9M
This Quarter Return
+15.5%
1 Year Return
-6.87%
3 Year Return
+443.49%
5 Year Return
+535.97%
10 Year Return
–
AUM
$146M
AUM Growth
+$146M
(+13%)
Cap. Flow
+$1.28M
Cap. Flow
% of AUM
0.88%
Top 10 Holdings %
Top 10 Hldgs %
90.62%
Holding
26
New
3
Increased
4
Reduced
10
Closed
8
Top Buys
| 1 |
Intellia Therapeutics
NTLA
|
$16.3M |
| 2 |
ALDR
Alder Biopharmaceuticals, Inc.
ALDR
|
$8.03M |
| 3 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$6.83M |
| 4 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$3.21M |
| 5 |
SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
|
$2.72M |
Top Sells
| 1 |
Wave Life Sciences
WVE
|
$9.14M |
| 2 |
RGLS
Regulus Therapeutics
RGLS
|
$5.47M |
| 3 |
Sangamo Therapeutics
SGMO
|
$3.3M |
| 4 |
XENT
Intersect ENT, Inc
XENT
|
$3.2M |
| 5 |
Larimar Therapeutics
LRMR
|
$3.08M |
Sector Composition
| 1 | Healthcare | 82.01% |
